Startup Tax Strategies - Decoding R&D, 83(b), 409A, and QSBS Rules for Maximum Benefit

On Tuesday, February 18th from 12 -1pm, John Pennett, Partner-in-Charge of the National Technology and Life Sciences Group at EisnerAmper, will offer strategy tips for year-end tax planning. 

Recent changes to the tax law regarding research and development expenditures have both a positive and a negative impact on early stage companies, especially those who are operating under government grant programs. 

This live webinar will explain how to navigate these rules and also touch on a couple of other key ownership topics (83b, 409a and QSBS) for startup companies.